Viewing Study NCT03147612


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-03-10 @ 6:47 AM
Study NCT ID: NCT03147612
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-13
First Post: 2017-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module